HOMECROFT SURGERY
HOMECROFT SURGERY, VOGUEBELOTH,ILLOGAN, REDRUTH, CORNWALL
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 19 | 39 | 48.7% | |
| HF 4 | 2011 | 26 | 41 | 63.4% | |
| HF 4 | 2012 | 30 | 41 | 73.2% | |
| HF 4 | 2013 | 25 | 35 | 71.4% | |
| HF004 | 2014 | 28 | 42 | 66.7% | |
| HF004 | 2015 | 32 | 34 | 94.1% |
